Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-006-7 | CAS number: 124728-62-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test material was non-mutagenic in the Salmonella typhimurium and Escherichia coli reverse mutation assay.
The test material is considered to be non-clastogenic in the chromosome aberration test with and without S9 mix, when tested up to precipitating concentrations.
The test item is considered to be non-mutagenic in the HPRT assay.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 07.09.2007- 18.02.2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Principles of method if other than guideline:
- None
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- HIS operon (S. thyphimurium), TRY operon (E. coli)
- Species / strain / cell type:
- S. typhimurium TA 1535
- Details on mammalian cell type (if applicable):
- his G 46, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 1537
- Details on mammalian cell type (if applicable):
- his C 3076, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 98
- Details on mammalian cell type (if applicable):
- his D 3052, uvrB, rfa + R-factor
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 100
- Details on mammalian cell type (if applicable):
- his G 46, uvrB, rfa + R-factor
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 102
- Details on mammalian cell type (if applicable):
- his G 428, rfa + R-factor
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- E. coli WP2
- Details on mammalian cell type (if applicable):
- his C 3076, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the tryptophan operon
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver homogenate (S9 mix) with standard co-factors with metabolic activation (Aroclor)
- Test concentrations with justification for top dose:
- In the pre-experiment the concentration range of the test item was 3 - 5000 μg/plate. The pre-experiment is reported as experiment 1. Since no relevant toxic effects were observed 5000 μg/plate were chosen as maximal concentration. Due to the observed precipitation eight concentrations were tested in experiment II. The concentration range included two logarithmic decades. The following concentrations were tested: 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO (> 99 %)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 2-aminoanthracene, 4-nitro-o-phenylene-diamine
- Evaluation criteria:
- A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and TA 102) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed. A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range. - Statistics:
- No statistical evaluation of the data is required.
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Please refer to confidential file under "Attachments".
- Conclusions:
- The test material was non-mutagenic in the Salmonella typhimurium and Escherichia coli reverse mutation assay.
- Executive summary:
The information for this endpoint study record was obtained from an experimental study. The OECD GLP criteria were met and the methods applied are fully compliant with OECD 471. This study was performed to investigate the potential of the test material to induce gene mutations according to the plate incorporation test (experiment I) and the preincubation test (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and TA 102. The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at the concentrations of 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate in pre-experiment/experiment I and II. The plates incubated with the test item showed normal background growth up to 5000 μg/plate with and without S9 mix in all strains used. No toxic effects, evident as a reduction in the number of revertants (below the induction factor of 0.5), occurred in the test groups with and without metabolic activation. Only in strain TA 1537 a minor reduction in the number of revertants (below the induction factor of 0.5) was observed at 5000 μg/plate in exp. I with S9 mix and in exp. II without S9 mix. No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with the test item at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies. In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. Therefore, the test material is considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Oct 04, 2007 - Feb 22, 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Principles of method if other than guideline:
- none
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM (Seromed, Berlin) including 10% (v/v) FCS (PAA Laboratories GmbH, Cölbe)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix (induction using PB/NBF)
- Test concentrations with justification for top dose:
- Experiment S9 Treatment+Recovery Vehicle Concentration
I - 4+14 hours DMSO 0.4, 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, and 50 µg/mL
II - 18 hours DMSO 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100 µg/mL
II - 28 hours DMSO 3.1, 6.3, 12.5, 25.0, 50.0 and 100 µg/mL
I + 4+14 hours DMSO 0.4, 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, and 50 µg/mL - Vehicle / solvent:
- Name: DMSO
Purity: 99.5 % (GC)
Final concentration in medium: 0.5 % (v/v) - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- other: Griseofulvin
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration:
Continous for 20 and 44 hours
Pulse for 3 + 14 and 3+41 hours
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: Solvent control: 4; others: 2
NUMBER OF CELLS EVALUATED: 100 metaphases (structural abberations)
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; relative total growth
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- A test article is considered as positive in this assay if:
1. the proportions of cells with structural aberrations at one or more concentration exceeds the normal range in both replicate cultures, and
2. a statistically significant increase in the proportion of cells with structural aberrations (excluding gaps) occurs at these doses. Increased incidence of cells with gaps or increased proportions of cells with structural aberrations not exceeding the normal range, or occurring only at very high or very toxic concentrations are likely to be concluded as "equivocal". Full assessment of the biological importance of such increases is likely only to be possible with reference to data from other test systems. Evidence of a dose-related effect is considered useful but not essential in the evaluation of a positive result. Cells with exchange aberrations or cells with greater than one structural aberration occur very infrequently in negative control cultures. Their appearance is therefore considered to be of particular biological significance. - Statistics:
- Standard statistical methods have been applied for data processing.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: yes (>= 50 µg/mL)
- Cytotoxicity: no
Please refer to attached document under "Overall remarks, attachments". - Conclusions:
- The test material is considered to be non-clastogenic in this chromosome aberration test with and without S9 mix, when tested up to precipitating concentrations.
- Executive summary:
The test item, suspended in DMSO, was assessed for its potential to induce structural chromosome aberrations in V79 cells of the Chinese hamster in vitro in two independent experiments. Each concentration was prepared individually because of poor test item solubility. The following study design was performed:
Experiment
S9
Treatment
Recovery
Vehicle
Concentrations
I
-
4
14
DMSO
0.4, 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, and 50 µg/mL
II
-
18
0
DMSO
0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100 µg/mL
II
-
28
0
DMSO
3.1, 6.3, 12.5, 25.0, 50.0 and 100 µg/mL
I
+
4
14
DMSO
0.4, 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, and 50 µg/mL
In each experimental group two parallel cultures were set up. Per culture 100 metaphases were scored for structural chromosome aberrations, except for the positive controls in Experiment II without metabolic activation at preparation intervals 18 and 28 hours, where only 50 metaphases were scored.
In the pre-test on toxicity 900 µg/mL (approx. 2.5 mM) was used as a top concentration due to results obtained in a solubility test. However, no homogeneous solution could be prepared. Therefore, we considered to weigh each implemented concentration individually in the main experiments in order to achieve the aimed concentrations.
This study was performed according to GLP and the methods applied are fully compliant with OECD 473.In the absence and the presence of S9 mix, no cytotoxicity was observed up to the highest applied concentration where precipitation occurred.
No clastogenicity was observed at the concentrations evaluated, either with or without metabolic activation. In Experiment I in the presence of S9 mix two statistically significant increases in the number of aberrant cells, excluding gaps (3.0 % each) were observed after treatment with 12.5 and 50 µg/mL. However, there was no dose-dependency and both values were within the range of the laboratory's historical control data (0.0 - 4.0 % aberrant cells, excluding gaps). Therefore, this observation has to be regarded as biologically irrelevant. No relevant increase in the frequencies of polyploid metaphases was found after treatment with the test item as compared to the frequencies of the controls. Appropriate mutagens were used as positive controls. They induced statistically significant increases (p < 0.05) in cells with structural chromosome aberrations.In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce structural chromosome aberrations as determined by the chromosome aberration test in V79 cells (Chinese hamster cell line) in vitro.
Therefore, the test material is considered to be non-clastogenic in this chromosome aberration test with and without S9 mix, when tested up to precipitating concentrations.- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 January 2018 until 07 February 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation test using the Hprt and xprt genes
- Target gene:
- HPRT
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: MEM
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- Due to the limited capacity for metabolic activation of potential mutagens in in vitro methods an exogenous metabolic activation system is necessary.
Phenobarbital/b-naphthoflavone induced rat liver S9 was used as metabolic activation system. The S9 was prepared and stored according to the currently valid version of the Envigo SOP for rat liver S9 preparation. Each batch of S9 was routinely tested for its capability to activate the known mutagens benzo[a]pyrene and 2-aminoanthracene in the Ames test.
An appropriate quantity of S9 supernatant was thawed and mixed with S9 cofactor solution to result in a final protein concentration of 0.75 mg/mL in the cultures. S9 mix contained MgCl2(8 mM), KCl (33 mM), glucose-6-phosphate (5 mM) and NADP (4 mM) in sodium-ortho-phosphate-buffer (100 mM, pH 7.4).
The protein concentration of the S9 preparation was 32.7 mg/mL (Lot. No.: 270717) in the pre-experiment and in the main experiment. - Test concentrations with justification for top dose:
- 4 hours treatment without S9 mix: 1.6, 3.1, 12.5, 25.0 (p), 50.0 (p), 100.0 (p), 200.0 (p) µg/mL
4 hours treatment with S9 mix: 1.6, 3.1, 12.5, 25.0 (p), 50.0 (p), 100.0 (p), 200.0 (p) µg/mL
p = precipitation visible to the unaided eye at the end of treatment
The concentrations used in the main experiment were selected based on precipitation observed in the pre-experiment.
The cultures at 50.0 µg/mL and above with and without metabolic activation were not evaluated for mutagenicity to avoid analysis of too many precipitating concentrations. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: tetrahydrofuran (THF)
- Justification for choice of solvent/vehicle: solubility properties of test item in THF and aqueous media - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: Experiment I: 4 hours with and without metabolic activation, Experiment II: 24 hours without metabolic activation, 4 hours with metabolic activation
- Expression time (cells in growth medium): 72 hours
- Selection time (if incubation with a selection agent): 10 days
SELECTION AGENT (mutation assays): 6-Thioguanine
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: >1.5x10exp. 6
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A test item is classified as positive if it induces a concentration-related increase of the mutant frequency exceeding the historical solvent control range.
A test item producing no concentration-related increase of the mutant frequency above the historical solvent control range is considered to be non-mutagenic in this system.
A mutagenic response is described as follows:
The test item is classified as mutagenic if it induces with at least one of the concentrations in both parallel cultures a mutation frequency that exceeds the historical negative and solvent control data range (95 % confidence interval limits).
The increase should be significant and dose dependent as indicated by statistical analysis (linear regression, least squares). - Statistics:
- A linear regression (least squares, calculated using a validated excel spreadsheet) was performed to assess a possible dose dependent increase of mutant frequencies. The numbers of mutant colonies generated with the test item were compared to the solvent control groups. A trend is judged as significant whenever the p-value (probability value) is below 0.05. However, both, biological and statistical significance were considered together.
Linear Regression Analysis:
experimental group / p-value *
without S9 mix: 0.495
with S9 mix: 0.507
*calculated for the mean mutant frequencies of culture I and II - Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Not effected (pH 7.40 in the solvent control versus pH 7.39 at 500.0 µg/mL)
- Effects of osmolality: No relevant increase (345 mOsm in the solvent control versus 371 mOsm at 500 µg/mL)
- Evaporation from medium: Not examined
- Precipitation: determined at 25.0 - 200.0 µg/mL
- Other confounding effects: None
RANGE-FINDING/SCREENING STUDIES:
According to the current OECD Guideline for Cell Gene Mutation Tests at least four analysable concentrations should be used in two parallel cultures. For freely-soluble and non-cytotoxic test items the maximum concentration should be 2 mg/mL, 2 µL/mL or 10 mM, whichever is the lowest. For cytotoxic test items the maximum concentration should result in approximately 10 to 20 % relative survival or cell density at subcultivation and the analysed concentrations should cover a range from the maximum to little or no cytotoxicity. Relatively insoluble test items should be tested up to the highest concentration that can be formulated in an appropriate solvent as solution or homogenous suspension. These test items should be tested up to or beyond their limit of solubility. Precipitation or phase separation should be evaluated at the beginning and at the end of treatment by the unaided eye.
The pre-experiment was performed in the presence and absence of metabolic activation. Test item concentrations between 3.9 µg/mL and 500 µg/mL were used. The highest concentration was chosen based on the solubility properties of the test item.
No relevant cytotoxic effect, indicated by a relative cloning efficiency of approx. 50 % or below was observed up to the highest concentration with and without metabolic activation.
The test medium was checked for precipitation or phase separation at the end of each treatment period (4 hours) before the test item was removed. Precipitation occurred at 125 µg/mL and above in the presence and absence of metabolic activation.
There was no relevant shift of pH and osmolarity of the medium even at the maximum concentration of the test item.
The concentrations used in the main experiment were selected based on precipitation observed in the pre-experiment. The individual concentrations were spaced by a factor of 2.
To overcome problems with possible deviations in toxicity the main experiment was started with more than four concentrations.
COMPARISON WITH HISTORICAL CONTROL DATA: Complies
ADDITIONAL INFORMATION ON CYTOTOXICITY:
No relevant cytotoxic effect indicated by an adjusted cloning efficiency I below 50 % in both cultures occurred up to the maximum concentration with and without metabolic activation. - Conclusions:
- In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the test item is considered to be non-mutagenic in this HPRT assay.
- Executive summary:
The study was performed to investigate the potential of the test item to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster according to OECD 476.
The treatment period was 4 hours with and without metabolic activation.
The maximum test item concentration of the pre-experiment (500 µg/mL) was based on the solubility properties of the test item. The highest concentration in the main experiment (200.0 µg/mL) was limited by precipitation observed in the pre-experiment.
No relevant and reproducible increase in mutant colony numbers/106 cells was observed in the main experiment up to the maximum concentration.
No cytotoxic effects indicated by an adjusted cloning efficiency below 50 % was observed neither in absence nor presence of metabolic activation.
Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the test item is considered to be non-mutagenic in this HPRT assay.
Referenceopen allclose all
See attchment
Summary Table
relative | relative | rel. adjusted | mutant | 95% | ||||
conc. | P | S9 | cloning | cell | cloning | colonies/ | confidence | |
µg/mL | mix | efficiency I | density | efficiency I | 106cells | interval | ||
% | % | % | ||||||
Solvent control with THF | - | - | 100.0 | 100.0 | 100.0 | 13.7 | 1.7 - 30.2 | |
Positive control (EMS) | 300.0 | - | - | 93.0 | 86.1 | 80.2 | 191.8 | 1.7 - 30.2 |
Test item | 1.6 | - | - | 98.6 | 86.2 | 84.9 | 19.2 | 1.7 - 30.2 |
Test item | 3.1 | - | - | 97.8 | 86.6 | 84.5 | 22.4 | 1.7 - 30.2 |
Test item | 6.3 | - | - | 98.2 | 81.1 | 79.4 | 11.9 | 1.7 - 30.2 |
Test item | 12.5 | - | - | 88.3 | 83.8 | 73.0 | 21.1 | 1.7 - 30.2 |
Test item | 25.0 | P | - | 87.0 | 57.8 | 50.9 | 11.5 | 1.7 - 30.2 |
Test item | 50.0 | P | - | # | # | # | # | # |
Test item | 100.0 | P | - | # | # | # | # | # |
Test item | 200.0 | P | - | # | # | # | # | # |
Solvent control with THF | - | + | 100.0 | 100.0 | 100.0 | 20.1 | 2.0 - 29.4 | |
Positive control (DMBA) | 2.3 | - | + | 69.0 | 99.2 | 68.0 | 135.4 | 2.0 - 29.4 |
Test item | 1.6 | - | + | 90.4 | 92.7 | 84.4 | 13.7 | 2.0 - 29.4 |
Test item | 3.1 | - | + | 83.3 | 95.6 | 80.3 | 20.6 | 2.0 - 29.4 |
Test item | 6.3 | - | + | 86.6 | 94.4 | 82.2 | 23.7 | 2.0 - 29.4 |
Test item | 12.5 | - | + | 84.8 | 92.6 | 79.0 | 18.0 | 2.0 - 29.4 |
Test item | 25.0 | P | + | 75.3 | 87.2 | 66.9 | 22.1 | 2.0 - 29.4 |
Test item | 50.0 | P | + | 75.9 | 104.0 | 78.9 | # | # |
Test item | 100.0 | P | + | # | # | # | # | # |
Test item | 200.0 | P | + | # | # | # | # | # |
P = precipitation visible to the unaided eye at the end of treatment
# culture was not continued to avoid analysis of too many precipitating concentrations
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
OECD 471
The information for this endpoint study record was obtained from an experimental study. The OECD GLP criteria were met and the methods applied are fully compliant with OECD 471. This study was performed to investigate the potential of the test material to induce gene mutations according to the plate incorporation test (experiment I) and the preincubation test (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and TA 102. The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at the concentrations of 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate in pre-experiment/experiment I and II. The plates incubated with the test item showed normal background growth up to 5000 μg/plate with and without S9 mix in all strains used. No toxic effects, evident as a reduction in the number of revertants (below the induction factor of 0.5), occurred in the test groups with and without metabolic activation. Only in strain TA 1537 a minor reduction in the number of revertants (below the induction factor of 0.5) was observed at 5000 μg/plate in exp. I with S9 mix and in exp. II without S9 mix. No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with the test item at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies. In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. Therefore, the test material is considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay.
OECD 473
The test item, suspended in DMSO, was assessed for its potential to induce structural chromosome aberrations in V79 cells of the Chinese hamster in vitro in two independent experiments. Each concentration was prepared individually because of poor test item solubility. The following study design was performed:
Experiment | S9 | Treatment | Recovery | Vehicle | Concentrations |
I | - | 4 | 14 | DMSO | 0.4, 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, and 50 µg/mL |
II | - | 18 | 0 | DMSO | 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, 50.0 and 100 µg/mL |
II | - | 28 | 0 | DMSO | 3.1, 6.3, 12.5, 25.0, 50.0 and 100 µg/mL |
I | + | 4 | 14 | DMSO | 0.4, 0.8, 1.6, 3.1, 6.3, 12.5, 25.0, and 50 µg/mL |
In each experimental group two parallel cultures were set up. Per culture 100 metaphases were scored for structural chromosome aberrations, except for the positive controls in Experiment II without metabolic activation at preparation intervals 18 and 28 hours, where only 50 metaphases were scored.
In the pre-test on toxicity 900 µg/mL (approx. 2.5 mM) was used as a top concentration due to results obtained in a solubility test. However, no homogeneous solution could be prepared. Therefore, we considered to weigh each implemented concentration individually in the main experiments in order to achieve the aimed concentrations.
This study was performed according to GLP and the methods applied are fully compliant with OECD 473.
In the absence and the presence of S9 mix, no cytotoxicity was observed up to the highest applied concentration where precipitation occurred.
No clastogenicity was observed at the concentrations evaluated, either with or without metabolic activation. In Experiment I in the presence of S9 mix two statistically significant increases in the number of aberrant cells, excluding gaps (3.0 % each) were observed after treatment with 12.5 and 50 µg/mL. However, there was no dose-dependency and both values were within the range of the laboratory's historical control data (0.0 - 4.0 % aberrant cells, excluding gaps). Therefore, this observation has to be regarded as biologically irrelevant. No relevant increase in the frequencies of polyploid metaphases was found after treatment with the test item as compared to the frequencies of the controls. Appropriate mutagens were used as positive controls. They induced statistically significant increases (p < 0.05) in cells with structural chromosome aberrations.
In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce structural chromosome aberrations as determined by the chromosome aberration test in V79 cells (Chinese hamster cell line) in vitro.
Therefore, the test material is considered to be non-clastogenic in this chromosome aberration test with and without S9 mix, when tested up to precipitating concentrations.
OECD 476
The study was performed to investigate the potential of the test item to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster according to OECD 476.
The treatment period was 4 hours with and without metabolic activation.
The maximum test item concentration of the pre-experiment (500 µg/mL) was based on the solubility properties of the test item. The highest concentration in the main experiment (200.0 µg/mL) was limited by precipitation observed in the pre-experiment.
No relevant and reproducible increase in mutant colony numbers/106 cells was observed in the main experiment up to the maximum concentration.
No cytotoxic effects indicated by an adjusted cloning efficiency below 50 % was observed neither in absence nor presence of metabolic activation.
Appropriate reference mutagens, used as positive controls, induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test system and the activity of the metabolic activation system.
In conclusion it can be stated that under the experimental conditions reported the test item did not induce gene mutations at the HPRT locus in V79 cells. Therefore, the test item is considered to be non-mutagenic in this HPRT assay.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. Based on available data, the test item does not require classification for genetic toxicity according to Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.